CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-12 | Ives Jeffrey L. Director | Exercise or conversion | +2,500 | $9.94 | $25K | 8,500 |
| 2020-05-12 | Ives Jeffrey L. Director | Sale | −2,500 | $16.00 | $40K | 6,000 |
| 2020-05-12 | Ives Jeffrey L. Director | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 1,000 | ||
| 2020-04-21 | Ives Jeffrey L. Director | Exercise or conversion | +2,500 | $9.94 | $25K | 8,500 |
| 2020-04-21 | Ives Jeffrey L. Director | Sale | −2,500 | $16.00 | $40K | 6,000 |
| 2020-04-21 | Ives Jeffrey L. Director | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 3,500 | ||
| 2020-04-21 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | −2,721 | $15.56 | $42K | 38,382 |
| 2020-04-21 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | −12,894 | $15.58 | $201K | 104,492 |
| 2020-04-21 | CHALMERS DEREK T President & CEO | Sale | −6,348 | $15.56 | $99K | 981,421 |
| 2020-04-17 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award | +8,334 | 41,103 | ||
| 2020-04-17 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award | +37,500 | 117,386 | ||
| 2020-04-17 | CHALMERS DEREK T President & CEO | Grant or award | +20,000 | 987,769 | ||
| 2020-03-04 | Ives Jeffrey L. Director | Exercise or conversion | +2,500 | $9.94 | $25K | 8,500 |
| 2020-03-04 | Ives Jeffrey L. Director | Sale | −2,500 | $16.00 | $40K | 6,000 |
| 2020-03-04 | Ives Jeffrey L. Director | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 6,000 | ||
| 2020-02-24 | Makara Richard VP, Head of Accting;Controller | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-02-24 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award | +16,000 | 32,769 | ||
| 2020-02-24 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award · Employee Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2020-02-24 | Goncalves Joana Chief Medical Officer | Grant or award | +16,000 | 16,000 | ||
| 2020-02-24 | Goncalves Joana Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,000 | 32,000 |
Page 14 of 15 · 284 trades